Literature DB >> 1908958

Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex.

K Abe1, R E Tanzi, K Kogure.   

Abstract

An induction of amyloid precursor protein (APP) mRNA was examined in a middle cerebral artery occlusion model of rats using Northern blot analyses. The level of tubulin mRNA was measured as an internal standard. With persistent focal ischemia, APP mRNA species which contain a Kunitz-type protease inhibitor (KPI) domain were induced in the rat cerebral cortex from 1 to 21 days after the insult with a maximum at 4 days, while total amounts of APP mRNA did not change. No change was observed in the level of tubulin mRNA. These results suggest a selective role of APP species which contain the KPI domain in focal cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908958     DOI: 10.1016/0304-3940(91)90020-t

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  30 in total

1.  Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein.

Authors:  F Zhang; C Eckman; S Younkin; K K Hsiao; C Iadecola
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

Review 2.  The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?

Authors:  D H Small
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 3.  Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.

Authors:  J Szczygielski; A Mautes; W I Steudel; P Falkai; T A Bayer; O Wirths
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

4.  K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus.

Authors:  C Heurteaux; V Bertaina; C Widmann; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

5.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease.

Authors:  G W Roberts; S M Gentleman; A Lynch; L Murray; M Landon; D I Graham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

6.  Molecular pathology of Alzheimer's disease.

Authors:  M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

7.  Argyrophilic plaque-like deposits in children.

Authors:  B J Crain; L McPhatter; D W Croom; C M Hulette
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path.

Authors:  J D Buxbaum; G Thinakaran; V Koliatsos; J O'Callahan; H H Slunt; D L Price; S S Sisodia
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 9.  Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.

Authors:  W Sue T Griffin; Robert E Mrak
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

10.  Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.